erythromycin has been researched along with Alloxan Diabetes in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, SL; Cui, DF; Fei, J; Liu, FL; Qin, XY; Wang, ZG | 1 |
| Makino, H; Nagase, R; Nishishita, S; Ogawa, D; Ohga, S; Okada, S; Sasaki, M; Shikata, K; Shikata, Y; Tone, A; Usui, H; Wada, J; Yozai, K | 1 |
| Ji, M; Lin, L; Lin, Z; Zhang, HJ; Zhao, ZQ | 1 |
| Jia, YD; Jiang, ZY; Liu, CQ; Tang, M | 1 |
| Hayashi, S; Itoh, Z; Kamei, K; Kawabe, Y; Matsuo, S; Monnai, M; Muramatsu, H; Omura, S; Onoma, M; Ozaki, K; Shiga, T; Suzuki, M; Takanashi, H; Yogo, K | 1 |
| Bali, JP; Cros, G; Serrano, JJ; Soulié, ML | 1 |
6 other study(ies) available for erythromycin and Alloxan Diabetes
| Article | Year |
|---|---|
Involvement of dopamine D3 and neuropeptide Y Y5 receptors in diabetic gastroparetic rats without response to erythromycin.
Topics: Animals; Diabetes Mellitus, Experimental; Erythromycin; Gastric Emptying; Gastrointestinal Agents; Gastroparesis; Gene Expression Regulation; Male; Oligonucleotide Array Sequence Analysis; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Neuropeptide Y; Reverse Transcriptase Polymerase Chain Reaction; RNA | 2003 |
Erythromycin ameliorates renal injury via anti-inflammatory effects in experimental diabetic rats.
Topics: Albuminuria; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemokine CCL2; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Erythromycin; Intercellular Adhesion Molecule-1; Kidney; Macrophages; NF-kappa B; Rats; Rats, Sprague-Dawley; Streptozocin; Transcription Factor RelA; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2005 |
Effect of erythromycin on gastric dysmotility and neuroendocrine peptides in rats with diabetes mellitus.
Topics: Animals; Diabetes Mellitus, Experimental; Erythromycin; Gastrointestinal Agents; Gastrointestinal Motility; Male; Motilin; Muscle Contraction; Muscle, Smooth; Pyloric Antrum; Rats; Rats, Sprague-Dawley; Somatostatin; Substance P; Vasoactive Intestinal Peptide | 2005 |
Expression of motilin in the hypothalamus and the effect of central erythromycin on gastric motility in diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Erythromycin; Gastrointestinal Agents; Gastrointestinal Motility; Hippocampus; Injections, Intraventricular; Male; Microinjections; Motilin; Neurons; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Receptors, Gastrointestinal Hormone; Receptors, Neuropeptide; Statistics, Nonparametric; Supraoptic Nucleus | 2007 |
Mitemcinal (GM-611), an orally active motilin receptor agonist, improves delayed gastric emptying in a canine model of diabetic gastroparesis.
Topics: Administration, Oral; Animals; Diabetes Mellitus, Experimental; Disease Models, Animal; Dogs; Erythromycin; Female; Gastric Emptying; Gastroparesis; Receptors, Gastrointestinal Hormone; Receptors, Neuropeptide | 2008 |
Impairment of contractile response to carbachol and muscarinic receptor coupling in gastric antral smooth muscle cells isolated from diabetic streptozotocin-treated rats and db/db mice.
Topics: Animals; Carbachol; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Erythromycin; Female; Guanosine 5'-O-(3-Thiotriphosphate); Insulin; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Muscle Contraction; Muscle, Smooth; N-Methylscopolamine; Pyloric Antrum; Rats; Receptors, Muscarinic; Scopolamine Derivatives; Streptozocin | 1992 |